Eastwick Pharmacy Care Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2801 Island Rd, Ste 10 11, Ahilo, PA 19153 Phone: 215-492-8800 Fax: 215-492-6421 |
News Archive
WellCare Health Plans, Inc. today reported results for the third quarter and nine months ended September 30, 2009. As determined under generally accepted accounting principles ("GAAP"), the Company reported net income of $28.7 million, or $0.68 per diluted share, for the third quarter 2009, compared with a net loss of $18.2 million, or $0.44 per diluted share, for the third quarter 2008.
A team of seven researchers collaborating from United States and Britain have found a way to use gene therapy to cure a rare form of childhood blindness that occurs due to a genetic predisposition.
The cover for issue 37 of Oncotarget features Figure 7, "The combination of romidepsin and KU60019 is synergistic in a xenograft model of MCL," by Scotto, et al. which reported that the antiproliferative effect induced by histone deactylase inhibitors is associated with the up-regulated expression of the cyclin-dependent kinase inhibitor p21.
Women's eNews examines U.N.'s new agency U.N. Women, which officially got off the ground on Jan. 3. According to the news service, U.N. Women's "Manhattan headquarters remain unoccupied, said U.N. Women spokesperson Gretchen Luchsinger"; employees from the previous U.N. entities that focused on women's issues remain in "scattered offices around the U.N. Secretariat building"; and "[s]even high-level staff positions" remain unfilled.
Advaxis, Inc., the live, attenuated Listeria monocytogenes immunotherapy company, announced today that it has entered into a definitive purchase agreement with Optimus Capital Partners, LLC d/b/a Optimus Life Sciences Capital Partners, LLC.
› Verified 3 days ago